HER2-low Hormone Receptor Positive Breast Cancer Clinical Trials
0 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Melanoma (Skin Cancer)HER2-low Hormone Receptor Positive Breast Cancer
Aminex Therapeutics, Inc.92 enrolled8 locationsNCT07287917
Recruiting
Phase 2
A Phase II Study of HLX22 in Combination With Trastuzumab Deruxtecan in HER2-low, Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer Patients
HER2-low Hormone Receptor Positive Breast Cancer
Shanghai Henlius Biotech50 enrolled1 locationNCT06832202